1. China Stocks

  2. •

    Finance

  3. •

    Financial conglomerates
ENTEST GROUP INC

ENTEST GROUP INC

OOTC:ETNI
0.00
USD
0.00
(0.00%)
0.00EPS
689,870.29Market Cap
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
TTM
Revenue per Share
- -
- -
2.63
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-16.4
-4.66
-7.18
-3.03
-0.43
-0.14
-0.03
-0.01
-0.01
-0.03
- -
- -
Free Cash Flow per Basic Share
-6.7
-1.89
-6.23
-1.46
-0.32
-0.14
- -
- -
-0.01
-0.03
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.7
-1.89
1.24
-0.09
-0.19
-0.05
-0.02
-0.02
-0.02
-0.03
-0.02
-0.02
Tangible Book Value per Share
0.7
-1.89
-1.69
-0.36
-0.19
-0.05
-0.02
-0.02
-0.02
-0.03
-0.02
-0.02
Basic Weighted Avg Shares
- -
- -
- -
1
3
10
17
40
43
49
49
49
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
-260.94
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
-1
-2
-1
-1
- -
-1
-1
-1
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-272.61
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
-1
-1
-1
-1
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
-1
-1
-1
-1
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-148.48
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
May'19
Aug'19
Nov'20
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
1
1
1
Shares Outstanding
49
49
49
Market Capitalization
1
1
1

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-130.98%
-341.73%
-86.7%
Free Cash Flow
143.14%
194.95%
-99.73%
Net Income, GAAP
27.25%
0.02%
-112.97%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
-0.01
-0.01
-0.02
-0.03
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Peiwen Yu
Full Time Employees
2
Sector
Finance
Industry
Financial conglomerates
Address
No. 911 Bao’an Book City Shenzhen GD China
IPO Date
Aug 11, 2009
Website
entestgroup.com
Similar Companies
Strategy Inc (NASDAQ:MSTR)
BitMine Immersion Technologies, Inc. (NYSE:BMNR)
Strive, Inc. (NASDAQ:ASST)
Hyperliquid Strategies Inc (NASDAQ:PURR)
Stablecoin Development Corporation (AMEX:SDEV)
Jio Financial Services Limited (NSE:JIOFIN)
Business
Entest Group, Inc. (ETNI) operates as a shell company with no significant current operations and seeks merger, acquisition, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination opportunities with one or more operating businesses. The company, founded in 2008 and headquartered at No. 911 Bao’an Book City, Xinqiao Street Central Road, Shenzhen, Guangdong Province, China, previously focused on biotechnology product development including immunotherapeutic cancer vaccines for dogs under its former name Entest Biomedical, Inc., which it changed to Entest Group, Inc. in February 2018; it employs two staff members and trades on the OTC Markets with Peiwen Yu as president, chief executive officer, and director. It generates no revenue, reports minimal EBITDA of around $44,000 on a trailing twelve-month basis, and maintains a small market capitalization under $5 million with negligible trading volume. No recent partnerships, funding rounds, acquisitions, new product launches, or major strategic shifts have been announced in the last several years, reflecting its dormant status in the shell companies segment of the financials sector targeting unidentified operating entities globally.